08:30 Joining to the Online Platform
08:45 Greeting from the Project Lead & GLC Icebreaker Session
08:55 Opening Remarks from the Chair
09:00 Sponsor Speech
09:15 How can RWE support Market Access team(s) in a post COVID landscape
09:45 Can Price Transparency Contribute to More Affordable Patient Access to Medicines?
10:15 Advanced analytics and RWE needs of HTA s/payers for Managed Entry
11:00 Market access in Alzheimer’s Disease
11:30 Do Value Based Contract support access to Rare Diseases?
12:00 Speed Date Networking Session
12:20 Lunch Break
13:00 What are the challenges of achieving greater collaboration among payers, HTA s, patients and pharma?
13:30 PANEL DISCUSSION: Philanthropy, social responsibility and drug pricing
14:10 Breath some fresh air
14:30 Same same, but different’: Entering the Rare Disease space – some considerations for a successful launch
15:00 What is the real value of pharmaceutical products in the digital era?
15:30 Closing remarks from the Chair
15:45 End of Day 1